Clarins USA, Inc. signs new full-floor lease with Empire State Realty Trust at 1400 Broadway

New York, NY Empire State Realty Trust, Inc. (NYSE: ESRT) announced that Clarins USA, Inc., a plant-based, French prestige skincare company, has signed a new lease with ESRT for a full-floor, 15,109 s/f space at 1400 Broadway. 

Located along the improved Broadway Pedestrian Plaza, 1400 Broadway provides easy access to transportation, dining, lodging, and entertainment for tenant enjoyment. Clarins will join  Signature Bank, IPG and Burlington Coat Factory, who have all expanded their presence in the 37-story building.

"We have made the decision to relocate our New York Headquarters Office to 1400 Broadway, to be in a more energy-efficient building that aligns with our corporate responsibility values," said Lionel Uzan, president of Clarins North America. "We intend to design a modern and versatile work environment to reflect the new needs of a mobile and agile workforce to foster collaboration, creativity, and social interactions, all in a more centrally-located area."

ESRT continues to attract high-quality tenants with spaces and buildings fully modernized and amenitized for the 21st century.

"We see a real flight to quality by tenants who recognize the value of our offer. Clarins' employees will enjoy a spectacular new tenant lounge and in-building food options and will benefit from ESRT's leadership in energy efficiency and superior indoor environmental quality," said Thomas P. Durels, executive vice president, real state at ESRT.

All ESRT buildings are equipped with industry-leading energy efficiency and indoor environmental quality measures which include MERV 13 filters and active bi-polar ionization. ESRT is committed to healthy buildings and confident return to office practices with frequent cleaning of public spaces and compliance with state and federal guidelines.

Tenant representation was provided by Scott Weiss of Savills. Representation for the property owner was provided by Ryan Kass of ESRT, and Scott J. Klau, Erik S. Harris, and Neil L. Rubin of Newmark.